Physician profile
Faisal Matto
NPI 1336579937
$37,534.57
in general payments reported to CMS, 2019-2025
13 companies · $1,188 in 2025
The $1,188 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,844 · 2020: $16K · 2021: $11K · 2022: $4,947 · 2023: $1,623 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,490 · Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,490.03 |
| Food and Beverage | $320.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $12,500.00 | 2020 | |
| Medtronic, INC. | $8,022.86 | 2021-2025 | Evera Mri Xt Dr Surescan, Arctic Front Advance |
| Boston Scientific Corporation | $7,634.16 | 2019-2023 | Emblem Mri S-Icd |
| Biotronik INC. | $4,214.71 | 2022 | |
| Medtronic Vascular, INC. | $2,683.51 | 2019 | |
| Medical Device Business Services, INC. | $1,517.70 | 2023 | Carto 3 |
| Philips North America LLC | $362.30 | 2022 | |
| Biosense Webster, INC. | $202.69 | 2023-2025 | Carto 3 |
| Abbott Laboratories | $178.70 | 2022 | |
| Edwards Lifesciences Corporation | $134.70 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.40 | 2021-2025 | Lifevest |
| Angiodynamics, INC. | $19.98 | 2025 | Alphavac |
| Cvrx, INC. | $12.86 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Matto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.